Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Nebojša Jović"'
Publikováno v:
Molecules, Vol 27, Iss 15, p 4899 (2022)
In this research, a UHPLC–MS/MS method was developed and validated for the determination of zonisamide in dried plasma spots (DPS) and dried blood spots (DBS). Detection of zonisamide and internal standard, 1-(2,3-dichlorphenyl)piperazine, was carr
Externí odkaz:
https://doaj.org/article/77ca0b0c9017424e979ca5f6362498dc
Autor:
Ruzica Kravljanac, Nebojša Jović, Djordje Kravljanac, Tatjana Pekmezovic, Biljana Vucetic Tadic
Publikováno v:
Seizure. 63:79-84
Purpose Evaluation of the etiology, clinical characteristics and outcome of the first status epilepticus (fSE) event in children. Method The patients with fSE hospitalized in our Institute from 1995 to 2011 were included. The etiology was characteriz
Autor:
Galina Stevanović, Stanka Romac, Miljana Kecmanovic, Milica Keckarević-Marković, Nebojša Jović, Dušan Keckarević
Publikováno v:
The Application of Clinical Genetics
Lafora disease (LD) is a fatal neurodegenerative disorder caused by loss-of-function mutations in either laforin glycogen phosphatase gene (EPM2A) or malin E3 ubiquitin ligase gene (NHLRC1). LD is associated with gradual accumulation of Lafora bodies
Autor:
Nebojša Jović
Publikováno v:
Journal of Pediatric Epilepsy. :077-085
Juvenile myoclonic epilepsy (JME) is a common form of idiopathic generalized epilepsy. Behavioral and cognitive problems are frequently observed in JME. Although the underlying mechanisms are still unknown, recent neuropsychological and neuroimaging
Autor:
Stanka Romac, P. Ignjatovic, Miljana Kecmanovic, Dušan Keckarević, Galina Stevanović, Nebojša Jović, Milica Keckarević-Marković
Publikováno v:
Clinical Genetics. 89:104-108
Lafora disease (LD) is an autosomal recessive, progressive disorder characterized by myoclonus and seizures, inexorable neurologic deterioration, cognitive decline and poor prognosis. LD is caused by mutations either in the EPM2A or in NHLRC1 genes.
Autor:
Nađa Kostić, Yannis Dotsikas, Nebojša Jović, Galina Stevanović, Mirjana Medenica, Anđelija Malenović
Publikováno v:
Journal of Chromatography B-Analytical Technologies in the Biomedical and Life Sciences
This paper presents a LC-MS/MS method for the determination of antiepileptic drug vigabatrin in dried plasma spots (DPS). Due to its zwitterionic chemical structure, a pre-column derivatization procedure was performed, aiming to yield enhanced ioniza
Autor:
Nebojša, Jović1
Publikováno v:
Vojnosanitetski Pregled: Military Medical & Pharmaceutical Journal of Serbia. Jul/Aug2002, Vol. 59 Issue 4, p363-367. 5p.
Autor:
Sonja Suvakov, Vesna Coric, Tatjana Simic, Jasmina Mimic-Oka, Dejana R. Jovanović, Tatjana Đukić, Marija Matic, Ljiljana Beslac-Bumbasirevic, Nebojša Jović, Marija Pljesa-Ercegovac, Ana Savic-Radojevic, Dragoslav Sokić, Aleksandar J. Ristić, Marko Ercegovac
Publikováno v:
Journal of Medical Biochemistry. 32:121-130
Summary Background: To get more insight into the effects of the most widely used antiepileptic drugs (AEDs) on the prooxidant/ antioxidant balance in epilepsy, a comparative analysis of the byproducts of oxidative damage and antioxidant de fense mech
Autor:
Žarko Ćojbašić, Bojko Bjelakovic, Stevo Lukic, Lidija Dimitrijevic, Mirjana Popovic, Ljiljana Bjelakovic, Nebojša Jović
Publikováno v:
Lukic, S, Cojbasic, Z, Jovic, N, Popovic, M, Bjelakovic, B, Dimitrijevic, L & Bjelakovic, L 2012, ' Artificial neural networks based prediction of cerebral palsy in infants with central coordination disturbance ', Early Human Development, vol. 88, no. 7, pp. 547-553 . https://doi.org/10.1016/j.earlhumdev.2012.01.001
Background In a previous study we demonstrated that heart variability parameters (HRV) could be helpful clinically as well as a prognostic tool in infants with central coordination disturbance (CCD). In recent years, outcome predictions using artific
Publikováno v:
Seizure. 20(7):520-525
Objectives To estimate the risk of seizure recurrence after antiepileptic drugs (AED) withdrawal and to identify related predictive features in patients with idiopathic generalized epilepsy (IGE) commencing at developing age (up to 16 year). Methods